Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00408525 · ClinicalTrials.gov registry record · Phase 1
Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease
A Phase 1 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 1
- Development phase
- 41
- Enrollment target
NCT00408525 is a Phase 1 study that has completed, run by Vanderbilt University. The registered enrollment target is 41 participants.
The verdict
NCT00408525, a Phase 1 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of the study is to examine patterns of brain activity in people who are at risk for memory problems (e.g., Alzheimer's disease or dementia)before and after the medication donepezil. Although genetic testing will be done, the results will not be shared with study participants. Once the genetic testing is completed subjects may continue to the second phase of the study. During this time they will be asked to take the medication donepezil (which is approved by the FDA for the treatment of Alzheimer's disease). Donepezil is not FDA approved for healthy volunteers and is therefore considered investigational in this study.
Interventions
- DRUG donepezil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2006-12 |
| Est. Completion | 2012-08-24 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00408525
The ClinicalTrials.gov registry entry for NCT00408525 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which donepezil is the first listed.
NCT00408525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00408525 about?
NCT00408525 is a clinical study titled "Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease". The purpose of the study is to examine patterns of brain activity in people who are at risk for memory problems (e.g., Alzheimer's disease or dementia)before and after the medication donepezil. Although genetic testing will be done, the results will not be shared with study participants. Once the g...
What is the current status of trial NCT00408525?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 41 participants. The study started on 2006-12. Estimated completion is 2012-08-24.
What interventions are being tested in trial NCT00408525?
The interventions under investigation include: donepezil (DRUG).
Who is sponsoring clinical trial NCT00408525?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.